Aravax’s mission is to revolutionise the lives of those with peanut allergy by removing the risk of life-threatening reactions to peanuts.
Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy. The company is using their proprietary technology to reset the immune system to tolerate peanut without evoking allergic reactions during treatment.
